Home › NDC Lookup › Ingredients › Prazosin Hydrochloride › 50090-8094-01
prazosin hydrochloride 1 mg Capsule, 30-count — NDC 50090-8094-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

prazosin hydrochloride 1 mg Capsule, 30-count — NDC 50090-8094-1 (Billing 50090-8094-01)

by A-S Medication Solutions · 30 CAPSULE in 1 BOTTLE

This is a package of 30 capsules of prazosin hydrochloride 1 mg Capsule from A-S Medication Solutions, marketed since Sep 2024 and currently FDA-listed. It is this product's only package size.

NDC 50090-8094-01
🏷️ FDA NDC (as labeled) 50090-8094-1 billing pads the package segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 2, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Prazosin Hydrochloride (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Mar 27, 2026 — cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. (Appco Pharma LLC) · FDA recall D-0419-2026
Class II · Mar 27, 2026 — cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. (Appco Pharma LLC) · FDA recall D-0420-2026
Class II · Mar 27, 2026 — cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. (Appco Pharma LLC) · FDA recall D-0421-2026
Class II · Oct 16, 2025 — Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit (Amerisource Health Services LLC) · FDA recall D-0103-2026
Class II · Oct 16, 2025 — Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit (Amerisource Health Services LLC) · FDA recall D-0102-2026
Class II · Oct 16, 2025 — Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit (Amerisource Health Services LLC) · FDA recall D-0101-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 50090-8094-1
Product NDC 50090-8094
11-digit billing NDC 50090809401
Application # ANDA216727
SPL Set ID 8e98b069-327a-4369-8094-879cca0ad0d9
Established class (EPC) alpha-Adrenergic Blocker
Mechanism of action Adrenergic alpha-Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-09-17
Route ORAL
Dosage form CAPSULE
Substance PRAZOSIN HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 50090-8094-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 50090-8094-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats high blood pressure. Bringing your pressure down lowers your risk of stroke and heart attack. It can be taken alone or with other blood pressure medicines like water pill...
  • Prazosin capsules are taken by mouth, usually two or three times a day at first. Your prescriber will start you low and raise the dose slowly based on your blood pressure. Take it...
  • Prazosin can drop your blood pressure quickly, especially in the first hours after a first dose or an increase. Dizziness is common, and fainting is less common. Be careful standin...
  • Dizziness, headache, drowsiness, low energy, weakness, palpitations and nausea are the most common. These often fade with continued use. Call your doctor if they are bothersome or...
📖 Read our full Prazosin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
1
Nutrient depletion considerations

Prazosin may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Prazosin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
50090-8094-01 You're viewing this Main listing 30 CAPSULE in 1 BOTTLE 2026-09-24 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Prazosin Hydrochloride 1 mg 59651-0271-01 Aurobindo 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 62332-0691-31 Alembic 100 capsules $0.084 AB Availability likely —
prazosin hydrochloride 1 mg 70756-0429-11 Lifestar 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 76282-0721-01 Exelan 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 00378-1101-01 Mylan 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 00904-7020-61 Major 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 51079-0630-20 Mylan 100 capsules $0.084 AB Availability likely —
prazosin hydrochloride 1 mg 72205-0275-90 Novadoz 90 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 70954-0019-10 ANI 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 68084-0996-01 American 100 capsules $0.084 AB Availability likely —
Prazosin hydrochloride 1 mg 70377-0066-11 Biocon 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 00093-4067-01 Teva 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 66993-0431-85 Prasco 90 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 70010-0084-01 Granules 100 capsules $0.084 AB Availability likely —
Prazosin Hydrochloride 1 mg 46708-0691-31 Alembic 100 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 50090-5695-00 A-S 100 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 63629-8750-01 Bryant 1000 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 63629-8756-01 Bryant 100 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 71335-1401-01 Bryant 30 capsules — AB Discontinued —
Prazosin Hydrochloride 1 mg 71335-1724-01 Bryant 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 71610-0693-30 Aphena 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 10135-0666-01 Marlex 100 capsules — AB FDA listed —
prazosin hydrochloride 1 mg 60760-0820-30 ST. 30 capsules — AB FDA listed —
prazosin hydrochloride 1 mg 70518-3669-00 REMEDYREPACK 60 capsules — AB Discontinued —
Prazosin Hydrochloride 1 mg 70518-4489-00 REMEDYREPACK 30 capsules — AB FDA listed —
prazosin hydrochloride 1 mg 71335-9648-01 Bryant 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 68788-7335-01 Preferred 100 capsules — AB FDA listed —
Prazosin hydrochloride 1 mg 70518-3928-00 REMEDYREPACK 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 70518-4457-00 REMEDYREPACK 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 67046-0680-03 Coupler 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 48433-0084-20 Safecor 100 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 55154-4156-00 Cardinal 10 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 55154-8181-00 Cardinal 10 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 55289-0536-60 PD-Rx 60 capsules — AB FDA listed —
prazosin hydrochloride 1 mg 76420-0523-01 ASCLEMED 100 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 00615-8519-39 NCS 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 70518-3271-00 REMEDYREPACK 30 capsules — AB FDA listed —
Prazosin Hydrochloride 1 mg 87441-0067-01 Unit 30 capsules — AB FDA listed —
prazosin hydrochloride 1 mg 70518-4712-00 REMEDYREPACK 30 capsules — AB FDA listed —
prazosin hydrochloride 1 mgthis 50090-8094-01 A-S 30 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Sep 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeCapsule
ImprintMP15
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII WZH3C48M4T
    Potassium hydroxide is a strong alkaline chemical used in medicines to adjust and maintain the pH level of liquid formulations, helping keep the product stable and the active ingredients effective.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII MB5IUD6JUA
    Shellac is a natural resin secreted by lac beetles, purified and processed into a coating material. It seals and protects tablets and capsules, controls how quickly the medicine dissolves, and gives pills their glossy finish.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

12 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerA-S Medication Solutions
Application holderMSN LABORATORIES PRIVATE LTD
FDA applicationANDA216727 (ANDA)
Labeler code50090
First marketedSep 2024
Product typeHuman Prescription Drug
Portfolio2,811 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by A-S Medication Solutions. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
A-S Medication Solutions is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 50090-8092-00 · A-S 50095-0001-25 · ALKALOIDA →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.